Statistics for miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis
Total visits
views | |
---|---|
miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis | 226 |
Total visits per month
views | |
---|---|
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
File Visits
views | |
---|---|
or-38-05-2717.pdf | 196 |
java.util.UUID:dd72cd6d-1c3e-4973-9b5f-491b51abbc64 | 43 |
java.util.UUID:e9ea31ef-3df0-4ee7-8954-22f5aad490d9 | 7 |
java.util.UUID:edbdf6c6-9952-48d6-9bf6-7af07c5c5216 | 6 |
Top country views
views | |
---|---|
United States | 175 |
Germany | 12 |
Sweden | 6 |
Ukraine | 6 |
Russia | 3 |
Canada | 2 |
United Kingdom | 1 |
Malaysia | 1 |
Top city views
views | |
---|---|
Wilmington | 46 |
Fairfield | 29 |
Houston | 18 |
Cambridge | 12 |
Ann Arbor | 9 |
Kiez | 9 |
Jacksonville | 7 |
White Plains | 6 |
Kiev | 5 |
Stockholm | 5 |
San Francisco | 3 |
Chicago | 2 |
Gunzenhausen | 2 |
Moscow | 2 |
Toronto | 2 |
Brooklyn | 1 |
Kansas City | 1 |
Lviv | 1 |
Motala | 1 |
Philadelphia | 1 |
Plauen | 1 |
Saint Petersburg | 1 |
Scottsdale | 1 |
Seattle | 1 |
Seremban | 1 |